abstract |
The present invention provides an agonistic anti-human CD40 antibody or a functional fragment thereof that is expected to have a higher therapeutic effect than conventional anti-human CD40 antibodies. An antibody acting on agonistic against CD40 or a functional fragment thereof. [Selection figure] None |